查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1500689

人乳寡糖市場 - 全球規模、佔有率、趨勢分析、機會、預測報告，2019-2030

Human Milk Oligosaccharides Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Product Type, By End Use Application, By Form, By Region
出版日期: | 出版商: Blueweave Consulting | 英文 235 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024年至2030年，全球人乳寡糖市場規模將以21.13%的複合年成長率大幅成長，2030年將達到2,5012萬美元。

全球人乳寡糖市場的蓬勃發展得益於兩個關鍵成分的共同作用：人乳寡糖(HMO) 和生長因子。 HMO 是嬰兒無法消化的複雜碳水化合物，可充當益生元，餵養腸道中的有益細菌並培養健康的微生物組。這種健康的腸道環境對寶寶免疫系統的發育有著重要作用。另一方面，生長因子是直接向身體細胞發出生長、成熟和發育訊號的蛋白質分子。

領先的策略諮詢和市場研究公司BlueWeave Consulting在最近的研究中估計，2023年全球人乳寡糖市場規模為1.0085億美元。 BlueWeave預測，在2024-2030年預測期內，全球人乳寡糖市場規模將以21.13%的複合年成長率擴大，到2030年將達到2.5012億美元。由於人們越來越認知到 HMO 對嬰兒的健康益處（包括促進免疫系統和腸道發育），全球人乳寡糖市場正在經歷顯著成長。這與父母為孩子尋求更天然和功能性食品的更廣泛趨勢是一致的。此外，添加 HMO 的嬰兒奶粉的日益普及正在推動需求，特別是在母乳哺​​育率較低的地區。最後，關於 HMO 對成人在消化器官系統健康和疾病預防等領域的潛在益處的研究正在創造新的市場機會，並進一步推動全球 HMO 市場的發展。

機會：機能性食品與健康領域快速成長的機會

人乳寡糖(HMO) 市場在各個領域提供了豐富而令人興奮的機會，這得益於對其健康益處的科學認知的不斷加深以及全球對創新機能性食品。嬰兒營養市場是 HMO 的主要動力，越來越多的父母尋求模仿母乳成分的嬰兒奶粉奶粉。 HMO 在支持嬰兒腸道發育和免疫力方面發揮著重要作用，完全符合天然和功能性成分的趨勢。隨著研究不斷揭示各種 HMO 的特異性功能，預計將有更多有針對性的奶粉能夠滿足特定嬰兒的需求。這種有針對性的方法相信將進一步推動嬰兒營養領域的 HMO 市場。 HMO 的應用遠遠超出了嬰兒奶粉。食品和飲料製造商正在認知到 HMO 在增強各種產品的營養成分方面的潛力。成人能量飲料、優格和穀類食品中的 HMO 強化可以滿足消費者對支持腸道健康和免疫力的機能性食品日益成長的興趣。此外，HMO 在運動營養產品中的潛在應用以幫助恢復和提高表現是另一個有前途的途徑。目前，HMO 的大規模生產依賴於複雜的酶促或化學合成過程。然而，使用微生物培養物或工程酵母菌株的發酵技術的進步對於經濟高效永續的HMO 生產具有巨大潛力。這不僅確保了穩定的供應以滿足不斷成長的需求，而且還可能降低富含 HMO 的產品的成本，使消費者更容易獲得這些產品。

地緣政治緊張局勢對全球人乳寡糖市場的影響

全球人乳寡糖（HMO）市場雖然充滿機遇，但由於地緣政治緊張局勢而面臨重大挑戰。這些緊張局勢可能會擾亂供應鏈，影響原料供應，影響消費者信心，並可能阻礙市場的成長軌跡。複雜的國際貿易網路很容易陷入地緣政治衝突。在壓力時期實施的關稅、制裁和出口限制可能會嚴重擾亂原料和 HMO 成品的流動。例如，HMO 合成所必需的關鍵酶的主要生產商可能位於政治不穩定的國家。這可能會導致缺貨和價格波動，影響製造商並最終影響消費者。此外，緊張的國際關係造成的物流瓶頸可能會進一步阻礙貨物的順利流動，造成延誤並可能導致產品損壞。 HMO 的生產取決於特定的原料，例如牛奶中的乳糖、酵素或微生物合成的前體。地緣政治緊張局勢可能會擾亂這些原料的採購，特別是如果它們來自經歷衝突或政治不穩定的地區。這可能導致供不應求和價格上漲，擠壓製造商的利潤並限制向消費者提供富含 HMO 的產品。地緣政治不穩定會帶來不確定性，並可能削弱消費者信心。這可能特別會影響機能性食品市場，例如富含 HMO 的產品，在經濟不確定的情況下，消費者可能會猶豫是否要花錢購買高級產品。此外，地緣政治緊張局勢導致的外匯波動可能會影響 HMO 生產和最終產品的整體成本，導致價格上漲，進一步抑制消費者需求。

全球人乳寡糖市場

全球人乳寡糖市場 - 副產品

根據產品類型，2'-岩藻糖基乳糖領域以 2'-FL 為主，它是母乳中天然存在的最豐富、研究最充分的 HMO 之一，在嬰兒營養和機能性食品應用中非常受歡迎。由於其結構與人類母乳中的寡糖相似，因此具有強大的生物學相關性和潛在的健康益處。其次，研究和開發表明，2'-FL 可以支持健康的腸道菌群，促進免疫系統發育，並降低嬰兒感染疾病和過敏的風險，並強調它對健康有正面影響。這些已證實的健康益處導致對含有 2'-FL 的產品的需求增加，例如嬰兒奶粉、嬰兒食品和營養食品。此外，生物技術製程的進步使得商業規模生產 2'-FL 成為可能，從而更容易配製到各種消費品中。這種可用性，加上消費者對 HMO 及其益處的認知不斷提高，正在推動 HMO 市場中 2'-FL 細分市場的成長。此外，監管部門的核准和醫療保健專業人員的支持進一步促進了 2'-FL 的崛起，鞏固了其作為全球 HMO 市場關鍵成長領域的地位。

全球人乳寡糖市場－依最終用途

由於母乳中天然豐富的人乳寡糖（HMO），嬰兒營養品產業預計在預測期內將顯著成長。 HMO 透過培養健康的腸道菌叢、增強免疫系統發育以及促進營養物質的消化和吸收，在嬰兒健康中發揮著至關重要的作用。由於母乳被認為是嬰兒營養的黃金標準，製造商努力在嬰兒奶粉中盡可能模仿母乳的成分，從而添加了 HMO。此外，HMO 被認為可以提供基本營養以外的益處，例如降低嬰兒感染疾病、過敏和發炎疾病的風險。這種付加的健康價值促使父母和醫療保健專業人員更喜歡添加 HMO 的嬰兒奶粉，從而增加了市場需求。

此外，研究和臨床研究不斷證明 HMO 對嬰兒健康結果有正面影響，進一步增強了對嬰兒奶粉的需求。衛生當局的監管核准和認可也促進了 HMO 濃縮嬰兒奶粉越來越被接受和採用，鞏固了其作為嬰兒營養中廣受歡迎的成分的地位。

全球人乳寡糖市場—依形式

根據形態，無定形粉末由於其優異的溶解度和生物利用度預計將在預測期內成長。由於其非結晶結構，非晶質粉末很容易溶解在液體中，例如嬰兒奶粉、飲料和營養食品。這項特性提高了其可用性，並使其能夠更好地融入各種食品和營養產品中，而不會犧牲質地或味道。

此外，與結晶質粉末相比，結晶質粉末通常具有更高的穩定性和保存期限，使其成為尋求長期產品穩定性和品質的製造商的首選。非晶質粉末的溶解度和穩定性增強，使其在市場上廣受歡迎，特別是在快速溶解、有效輸送和產品壽命是影響消費者滿意度和產品性能的關鍵因素的應用中。

全球人乳寡糖市場－按地區分類

關於人乳寡糖全球市場的詳細研究報告涵蓋了全球主要地區：北美、歐洲、亞太地區、拉丁美洲、中東和非洲。該地區專注於嬰幼兒營養和醫療保健，家長和醫療保健專業人員對幼兒營養的重要性有很高的認知。這種認知正在推動嬰兒奶粉和嬰兒食品中對 HMO 的需求，因為它們模仿了母乳的好處。此外，北美在食品和營養行業擁有先進的研發能力，導致基於 HMO 的產品不斷創新和產品進步。這項創新包括新配方、改進的生產技術和增強的產品功效，以吸引消費者並推動市場成長。此外，北美有利的法律規範和標準支持 HMO 的商業化和行銷，為市場擴張創造了有利的環境。主要市場參與者、強大的分銷網路和戰略合作夥伴關係的存在進一步促進了北美在全球 HMO 市場的主導地位，並對整體市場的成長和開拓做出了重大貢獻。

競爭格局

全球人乳寡糖市場分散，眾多參與者進入市場。全球人乳寡糖市場的主要公司包括BASF SE、Abbott Laboratories、Chr. Hansen Holding A/S、International Flavors & Fragrances Inc.（杜邦）、Koninklijke DSM NV、Merck &Co.Inc、Royal FrieslandCampina NV Inc.、ZuChem。 .、Inbiose NV、Glycosyn LLC、Kirin Holdings Company (Kyowa Hakko Bio)、Jennewein Biotechnologie GmbH、雀巢SA、InnoBio Ltd.、Elicityl SA。為了進一步增加市場佔有率，這些公司正在採取各種策略，例如併購、合作、合資、授權合約和新產品發布。公司採取的主要行銷策略是設施擴張、產品多元化、聯盟、合資、合作和收購，以擴大客戶範圍並在整個市場中獲得競爭優勢。

該報告的詳細分析提供了有關全球人乳寡糖市場的成長潛力、未來趨勢和統計數據的資訊。它還涵蓋了推動市場總規模預測的因素。該報告致力於提供全球人乳寡糖市場的最新技術趨勢以及產業見解，以幫助決策者做出明智的策略決策。此外，也分析了市場成長動力、挑戰和競爭動態。

目錄

第1章 研究框架

第 2 章執行摘要

第3章全球人乳寡糖市場洞察

  • 產業價值鏈分析
  • DROC分析
    • 生長促進因子
      • 提高對 HMO 益處的認知
      • 機能性食品日益受到關注
      • 優質嬰兒奶粉的需求增加
    • 抑制因素
      • 與傳統嬰兒奶粉的競爭
      • 消費者認知度與接受度
      • 生產成本高
    • 機會
      • 拓展新用途
      • HMO 生產的技術進步
      • 亞太地區和拉丁美洲不斷成長的市場
    • 任務
      • 監管障礙
      • 有限的科學研究
  • 科技進步/最新趨勢
  • 法律規範
  • 波特五力分析

第4章全球人乳寡糖市場：行銷策略

第5章全球人乳寡糖市場概況

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 產品類別
      • 2'-岩藻糖基乳糖
      • 乳-N-新四糖 (LNnT)
      • 3-岩藻糖基乳糖
      • 3'-SL（3'-唾液酸乳糖）
      • 6'-SL（6'-唾液酸乳糖）
      • 其他
    • 按最終用途
      • 嬰奶粉
      • 飲食補充劑
      • 機能性食品和飲料
    • 按形式
      • 無定形粉末
      • 結晶粉
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區 (APAC)
      • 拉丁美洲 (LATAM)
      • 中東和非洲 (MEA)

第6章 北美人乳寡糖市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 產品類別
    • 按最終用途
    • 按形式
    • 按國家/地區
      • 美國
      • 加拿大

第7章歐洲人乳寡糖市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 產品類別
    • 按最終用途
    • 按形式
    • 按國家/地區
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 其他歐洲國家

第8章亞太人乳寡糖市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 產品類別
    • 按最終用途
    • 按形式
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳洲/紐西蘭
      • 印尼
      • 馬來西亞
      • 新加坡
      • 越南
      • 亞太地區其他國家

第9章 拉丁美洲人乳寡糖市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 產品類別
    • 按最終用途
    • 按形式
    • 按國家/地區
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 其他拉丁美洲

第10章中東及非洲人乳寡糖市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 產品類別
    • 按最終用途
    • 按形式
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 科威特
      • 南非
      • 奈及利亞
      • 阿爾及利亞
      • 其他中東/非洲

第11章競爭格局

  • 主要企業及其產品列表
  • 2023年全球人乳寡糖市場佔有率分析
  • 競爭基準化分析：透過管理參數
  • 重大策略發展（合併、收購、聯盟等）

第12章地緣政治緊張局勢加劇對全球人乳寡糖市場的影響

第13章 公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人員、主要競爭對手、聯絡方式、策略展望、SWOT分析）

  • BASF SE
  • Abbott Laboratories
  • Chr. Hansen Holding A/S
  • International Flavors &Fragrances Inc.（DuPont）
  • Koninklijke DSM NV
  • Merck &Co. Inc.
  • Royal FrieslandCampina NV
  • ZuChem Inc.
  • Inbiose NV
  • Glycosyn LLC
  • Kirin Holdings Company（Kyowa Hakko Bio）
  • Jennewein Biotechnologie GmbH
  • Nestle SA
  • InnoBio Ltd.
  • Elicityl SA
  • 其他主要企業

第14章 主要策略建議

第15章調查方法

簡介目錄
Product Code: BWC23330

Global Human Milk Oligosaccharide Market Size Set Expands at Significant CAGR of 21.13% During 2024-2030 to Reach USD 250.12 Million by 2030

Global Human Milk Oligosaccharide Market is flourishing as the two key components working in tandem are human milk oligosaccharides (HMOs) and growth factors. HMOs, complex sugars indigestible by the infant, act as prebiotics, feeding the good bacteria in the gut and fostering a healthy microbiome. This healthy gut environment plays a crucial role in the baby's immune system development. Growth factors, on the other hand, are protein molecules that directly signal the body's cells to grow, mature, and develop.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Human Milk Oligosaccharide Market size at USD 100.85 Million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Human Milk Oligosaccharide Market size to expand at a CAGR of 21.13% reaching a value of USD 250.12 Million by 2030. The Global Human Milk Oligosaccharide Market is experiencing significant growth, propelled by rising awareness of the health benefits of HMOs for infants, including boosting their immune system and gut development. This aligns with a broader trend of parents seeking out more natural and functional foods for their children. Additionally, the growing popularity of infant formula with added HMOs is driving demand, particularly in regions with lower breastfeeding rates. Lastly, research into the potential benefits of HMOs for adults in areas like digestive health and disease prevention is creating new market opportunities, further propelling the global HMO market forward.

Opportunity: Burgeoning Opportunity in the Functional Food and Health Space

The human milk oligosaccharide (HMO) market presents a wealth of exciting opportunities across various segments, driven by increasing scientific understanding of their health benefits and a growing global demand for innovative functional foods. The infant nutrition market is a primary driver for HMOs, with parents increasingly seeking out infant formulas that mimic the composition of breast milk. HMOs play a crucial role in supporting infant gut development and immunity, aligning perfectly with this trend towards natural and functional ingredients. As research continues to unveil the specific functionalities of various HMOs, we can expect even more targeted formulas catering to specific infant needs. This targeted approach will further propel the HMO market within the infant nutrition sector. The application of HMOs extends far beyond infant formula. Food and beverage manufacturers are recognizing the potential of HMOs to enhance the nutritional profile of various products. HMO fortification in adult nutritional drinks, yogurts, and cereals can cater to growing consumer interest in functional foods that support gut health and immunity. Additionally, the potential application of HMOs in sports nutrition products to aid recovery and enhance performance is another promising avenue. Currently, large-scale production of HMOs relies on complex enzymatic or chemical synthesis processes. However, advancements in fermentation technology using microbial cultures or engineered yeast strains hold immense promise for cost-effective and sustainable HMO production. This will not only ensure a steady supply to meet growing demand but also potentially bring down the cost of HMO-fortified products, making them more accessible to consumers.

Impact of Geopolitical Tensions on Global Human Milk Oligosaccharide Market

The global human milk oligosaccharide (HMO) market, while brimming with opportunities, faces a significant challenge in the form of geopolitical tensions. These tensions can disrupt supply chains, influence raw material availability, and impact consumer confidence, potentially hindering the market's growth trajectory. The intricate web of international trade can be easily entangled by geopolitical conflicts. Tariffs, sanctions, and export restrictions implemented during times of tension can significantly disrupt the flow of raw materials and finished HMO products. For instance, a major producer of a key enzyme crucial for HMO synthesis might be located in a country experiencing political unrest. This can lead to shortages and price fluctuations, impacting manufacturers and ultimately consumers. Additionally, logistical bottlenecks arising from strained international relations can further impede the smooth movement of goods, creating delays and potentially causing product spoilage. HMO production relies on specific raw materials, such as lactose from milk and precursors for enzymatic or microbial synthesis. Geopolitical tensions can disrupt the sourcing of these raw materials, especially if they originate from regions experiencing conflict or political instability. This can lead to shortages and price hikes, squeezing profit margins for manufacturers and potentially limiting the availability of HMO-fortified products for consumers. Geopolitical instability can breed uncertainty and erode consumer confidence. This can particularly impact the market for functional foods like HMO-fortified products, where consumers might be hesitant to spend on premium offerings during uncertain economic times. Additionally, currency fluctuations arising from geopolitical tensions can affect the overall cost of HMO production and finished goods, potentially leading to price hikes that further dampen consumer demand.

Global Human Milk Oligosaccharide Market

Global Human Milk Oligosaccharides Market - By Product

Based on product type, 2'-Fucosyllactose segment is expected to grow in the forecast period as 2'-FL is one of the most abundant and well-studied HMOs naturally present in breast milk, making it highly desirable for infant nutrition and functional food applications. Its structural similarity to the oligosaccharides found in human milk gives it a strong biological relevance and potential health benefits. Secondly, research has highlighted the positive effects of 2'-FL on infant health, including its role in supporting a healthy gut microbiome, enhancing immune system development, and potentially reducing the risk of infections and allergies in infants. These documented health benefits have increased the demand for products containing 2'-FL, such as infant formulas, baby foods, and dietary supplements. Moreover, advancements in biotechnological processes have enabled the production of 2'-FL on a commercial scale, making it more accessible for incorporation into various consumer products. This availability, coupled with growing consumer awareness of HMOs and their benefits, has fueled the growth of the 2'-FL segment in the HMOs market. Additionally, regulatory approvals and endorsements from healthcare professionals further contribute to the prominence of 2'-FL, solidifying its position as a leading growth segment within the global HMOs market.

Global Human Milk Oligosaccharides Market - By End Use Application

The infant nutrition segment is anticipated to experience significant growth in the forecast period due to the natural abundance of Human Milk Oligosaccharides (HMOs) in human breast milk. HMOs play pivotal roles in infant health by fostering a healthy gut microbiome, bolstering immune system development, and facilitating the digestion and absorption of nutrients. As breast milk is considered the gold standard for infant nutrition, manufacturers strive to mimic its composition as closely as possible in infant formula, leading to the inclusion of HMOs. Furthermore, HMOs are believed to offer benefits that extend beyond basic nutrition, such as reducing the risk of infections, allergies, and inflammatory conditions in infants. This added health value drives parents and healthcare professionals to prefer infant formulas supplemented with HMOs, enhancing the market demand.

Furthermore, research and clinical studies continue to demonstrate the positive impact of HMOs on infant health outcomes, further bolstering their demand in infant formula. Regulatory approvals and endorsements from health authorities also contribute to the growing acceptance and adoption of HMO-enriched infant formulas, solidifying their position as a sought-after component in early childhood nutrition.

Global Human Milk Oligosaccharides Market - By Form

Based on Form, the amorphous Powder is expected to grow in the forecast period owing to its superior solubility and bioavailability. Amorphous Powder has a non-crystalline structure, which makes it easier to dissolve in liquids, such as infant formula, beverages, or dietary supplements. This property enhances its usability and allows for better incorporation into various food and nutritional products without compromising on texture or taste.

Additionally, Amorphous Powder typically exhibits improved stability and shelf-life compared to Crystalline Powder, making it a preferred choice for manufacturers seeking long-term product stability and quality. The enhanced solubility and stability of Amorphous Powder contribute to its higher demand in the market, especially in applications where quick dissolution, effective delivery, and product longevity are essential factors influencing consumer satisfaction and product performance.

Global Human Milk Oligosaccharides Market - By Region

The in-depth research report on the Global Human Milk Oligosaccharides Market covers several major regions across the globe: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The region has a strong emphasis on infant nutrition and healthcare, with a high awareness among parents and healthcare professionals regarding the importance of early childhood nutrition. This awareness drives the demand for HMOs in infant formula and baby foods, as they mimic the benefits of breast milk. Additionally, North America boasts advanced research and development capabilities in the food and nutrition industry, leading to continuous innovation and product advancements in HMO-based products. This innovation includes novel formulations, improved production techniques, and enhanced product efficacy, attracting consumers and boosting market growth. Additionally, favorable regulatory frameworks and standards in North America support the commercialization and marketing of HMOs, fostering a conducive environment for market expansion. The presence of key market players, strong distribution networks, and strategic partnerships further contribute to North America's dominant position in the global HMOs market, making it a significant contributor to overall market growth and development.

Competitive Landscape

The Global Human Milk Oligosaccharide Market is fragmented, with numerous players serving the market. Major players operating in the Global Human Milk Oligosaccharides Market include BASF SE, Abbott Laboratories, Chr. Hansen Holding A/S, International Flavors & Fragrances Inc. (DuPont), Koninklijke DSM N.V., Merck & Co. Inc., Royal FrieslandCampina N.V., ZuChem Inc., Inbiose NV, Glycosyn LLC, Kirin Holdings Company (Kyowa Hakko Bio), Jennewein Biotechnologie GmbH, Nestle S.A., InnoBio Ltd., Elicityl SA. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge in the overall market.

The report's in-depth analysis provides information about growth potential, upcoming trends, and the Global Human Milk Oligosaccharide Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Human Milk Oligosaccharide Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the market's growth drivers, challenges, and competitive dynamics.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Human Milk Oligosaccharide Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rising awareness of the benefits of HMOs
      • 3.2.1.2. Increasing focus on functional foods
      • 3.2.1.3. Growing demand for premium infant formula
    • 3.2.2. Restraints
      • 3.2.2.1. Competition from conventional infant formula
      • 3.2.2.2. Consumer perception and acceptance
      • 3.2.2.3. High cost of production
    • 3.2.3. Opportunities
      • 3.2.3.1. Expansion into new applications
      • 3.2.3.2. Technological advancements in HMO production
      • 3.2.3.3. Growing markets in Asia Pacific and Latin America
    • 3.2.4. Challenges
      • 3.2.4.1. Regulatory hurdles
      • 3.2.4.2. Limited scientific research
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Human Milk Oligosaccharide Market: Marketing Strategies

5. Global Human Milk Oligosaccharide Market Overview

  • 5.1. Market Size & Forecast, 2019-2030
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share and Forecast
    • 5.2.1. By Product Type
      • 5.2.1.1. 2'-Fucosyllactose
      • 5.2.1.2. Lacto-N-neotetraose (LNnT)
      • 5.2.1.3. 3-Fucosyllactose
      • 5.2.1.4. 3'-SL (3'-sialyllactose)
      • 5.2.1.5. 6'-SL (6'-sialyllactose)
      • 5.2.1.6. Others
    • 5.2.2. By End Use Application
      • 5.2.2.1. Infant Formula
      • 5.2.2.2. Dietary Supplement
      • 5.2.2.3. Functional Food & Beverages
    • 5.2.3. By Form
      • 5.2.3.1. Amorphous Powder
      • 5.2.3.2. Crystalline Powder
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. Asia Pacific (APAC)
      • 5.2.4.4. Latin America (LATAM)
      • 5.2.4.5. Middle East and Africa (MEA)

6. North America Human Milk Oligosaccharide Market

  • 6.1. Market Size & Forecast, 2019-2030
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End Use Application
    • 6.2.3. By Form
    • 6.2.4. By Country
      • 6.2.4.1. United States
      • 6.2.4.1.1. By Product Type
      • 6.2.4.1.2. By End Use Application
      • 6.2.4.1.3. By Form
      • 6.2.4.2. Canada
      • 6.2.4.2.1. By Product Type
      • 6.2.4.2.2. By End Use Application
      • 6.2.4.2.3. By Form

7. Europe Human Milk Oligosaccharide Market

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End Use Application
    • 7.2.3. By Form
    • 7.2.4. By Country
      • 7.2.4.1. Germany
      • 7.2.4.1.1. By Product Type
      • 7.2.4.1.2. By End Use Application
      • 7.2.4.1.3. By Form
      • 7.2.4.2. United Kingdom
      • 7.2.4.2.1. By Product Type
      • 7.2.4.2.2. By End Use Application
      • 7.2.4.2.3. By Form
      • 7.2.4.3. Italy
      • 7.2.4.3.1. By Product Type
      • 7.2.4.3.2. By End Use Application
      • 7.2.4.3.3. By Form
      • 7.2.4.4. France
      • 7.2.4.4.1. By Product Type
      • 7.2.4.4.2. By End Use Application
      • 7.2.4.4.3. By Form
      • 7.2.4.5. Spain
      • 7.2.4.5.1. By Product Type
      • 7.2.4.5.2. By End Use Application
      • 7.2.4.5.3. By Form
      • 7.2.4.6. Belgium
      • 7.2.4.6.1. By Product Type
      • 7.2.4.6.2. By End Use Application
      • 7.2.4.6.3. By Form
      • 7.2.4.7. Russia
      • 7.2.4.7.1. By Product Type
      • 7.2.4.7.2. By End Use Application
      • 7.2.4.7.3. By Form
      • 7.2.4.8. The Netherlands
      • 7.2.4.8.1. By Product Type
      • 7.2.4.8.2. By End Use Application
      • 7.2.4.8.3. By Form
      • 7.2.4.9. Rest of Europe
      • 7.2.4.9.1. By Product Type
      • 7.2.4.9.2. By End Use Application
      • 7.2.4.9.3. By Form

8. Asia Pacific Human Milk Oligosaccharide Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End Use Application
    • 8.2.3. By Form
    • 8.2.4. By Country
      • 8.2.4.1. China
      • 8.2.4.1.1. By Product Type
      • 8.2.4.1.2. By End Use Application
      • 8.2.4.1.3. By Form
      • 8.2.4.2. India
      • 8.2.4.2.1. By Product Type
      • 8.2.4.2.2. By End Use Application
      • 8.2.4.2.3. By Form
      • 8.2.4.3. Japan
      • 8.2.4.3.1. By Product Type
      • 8.2.4.3.2. By End Use Application
      • 8.2.4.3.3. By Form
      • 8.2.4.4. South Korea
      • 8.2.4.4.1. By Product Type
      • 8.2.4.4.2. By End Use Application
      • 8.2.4.4.3. By Form
      • 8.2.4.5. Australia & New Zealand
      • 8.2.4.5.1. By Product Type
      • 8.2.4.5.2. By End Use Application
      • 8.2.4.5.3. By Form
      • 8.2.4.6. Indonesia
      • 8.2.4.6.1. By Product Type
      • 8.2.4.6.2. By End Use Application
      • 8.2.4.6.3. By Form
      • 8.2.4.7. Malaysia
      • 8.2.4.7.1. By Product Type
      • 8.2.4.7.2. By End Use Application
      • 8.2.4.7.3. By Form
      • 8.2.4.8. Singapore
      • 8.2.4.8.1. By Product Type
      • 8.2.4.8.2. By End Use Application
      • 8.2.4.8.3. By Form
      • 8.2.4.9. Vietnam
      • 8.2.4.9.1. By Product Type
      • 8.2.4.9.2. By End Use Application
      • 8.2.4.9.3. By Form
      • 8.2.4.10. Rest of APAC
      • 8.2.4.10.1. By Product Type
      • 8.2.4.10.2. By End Use Application
      • 8.2.4.10.3. By Form

9. Latin America Human Milk Oligosaccharide Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End Use Application
    • 9.2.3. By Form
    • 9.2.4. By Country
      • 9.2.4.1. Brazil
      • 9.2.4.1.1. By Product Type
      • 9.2.4.1.2. By End Use Application
      • 9.2.4.1.3. By Form
      • 9.2.4.2. Mexico
      • 9.2.4.2.1. By Product Type
      • 9.2.4.2.2. By End Use Application
      • 9.2.4.2.3. By Form
      • 9.2.4.3. Argentina
      • 9.2.4.3.1. By Product Type
      • 9.2.4.3.2. By End Use Application
      • 9.2.4.3.3. By Form
      • 9.2.4.4. Peru
      • 9.2.4.4.1. By Product Type
      • 9.2.4.4.2. By End Use Application
      • 9.2.4.4.3. By Form
      • 9.2.4.5. Rest of LATAM
      • 9.2.4.5.1. By Product Type
      • 9.2.4.5.2. By End Use Application
      • 9.2.4.5.3. By Form

10. Middle East & Africa Human Milk Oligosaccharide Market

  • 10.1. Market Size & Forecast, 2019-2030
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By End Use Application
    • 10.2.3. By Form
    • 10.2.4. By Country
      • 10.2.4.1. Saudi Arabia
      • 10.2.4.1.1. By Product Type
      • 10.2.4.1.2. By End Use Application
      • 10.2.4.1.3. By Form
      • 10.2.4.2. UAE
      • 10.2.4.2.1. By Product Type
      • 10.2.4.2.2. By End Use Application
      • 10.2.4.2.3. By Form
      • 10.2.4.3. Qatar
      • 10.2.4.3.1. By Product Type
      • 10.2.4.3.2. By End Use Application
      • 10.2.4.3.3. By Form
      • 10.2.4.4. Kuwait
      • 10.2.4.4.1. By Product Type
      • 10.2.4.4.2. By End Use Application
      • 10.2.4.4.3. By Form
      • 10.2.4.5. South Africa
      • 10.2.4.5.1. By Product Type
      • 10.2.4.5.2. By End Use Application
      • 10.2.4.5.3. By Form
      • 10.2.4.6. Nigeria
      • 10.2.4.6.1. By Product Type
      • 10.2.4.6.2. By End Use Application
      • 10.2.4.6.3. By Form
      • 10.2.4.7. Algeria
      • 10.2.4.7.1. By Product Type
      • 10.2.4.7.2. By End Use Application
      • 10.2.4.7.3. By Form
      • 10.2.4.8. Rest of MEA
      • 10.2.4.8.1. By Product Type
      • 10.2.4.8.2. By End Use Application
      • 10.2.4.8.3. By Form

11. Competitive Landscape

  • 11.1. List of Key Players and Their Offerings
  • 11.2. Global Human Milk Oligosaccharide Market Share Analysis, 2023
  • 11.3. Competitive Benchmarking, By Operating Parameters
  • 11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

12. Impact of Escalating Geopolitical Tensions on Global Human Milk Oligosaccharide Market

13. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 13.1. BASF SE
  • 13.2. Abbott Laboratories
  • 13.3. Chr. Hansen Holding A/S
  • 13.4. International Flavors & Fragrances Inc. (DuPont)
  • 13.5. Koninklijke DSM N.V.
  • 13.6. Merck & Co. Inc.
  • 13.7. Royal FrieslandCampina N.V.
  • 13.8. ZuChem Inc.
  • 13.9. Inbiose NV
  • 13.10. Glycosyn LLC
  • 13.11. Kirin Holdings Company (Kyowa Hakko Bio)
  • 13.12. Jennewein Biotechnologie GmbH
  • 13.13. Nestle S.A.
  • 13.14. InnoBio Ltd.
  • 13.15. Elicityl SA
  • 13.16. Other Prominent Players

14. Key Strategic Recommendations

15. Research Methodology

  • 15.1. Qualitative Research
    • 15.1.1. Primary & Secondary Research
  • 15.2. Quantitative Research
  • 15.3. Market Breakdown & Data Triangulation
    • 15.3.1. Secondary Research
    • 15.3.2. Primary Research
  • 15.4. Breakdown of Primary Research Respondents, By Region
  • 15.5. Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable